Co-treatment of gonadotropin and letrozole in infertile women with endometriosis: A double-blind randomized clinical trial

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 46

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJRM-20-6_006

تاریخ نمایه سازی: 4 مرداد 1401

Abstract:

Background: The common causes of infertility in women with endometriosis are folliculogenesis alternation, steroidogenesis and fertilization impairment, oocyte and embryo quality reduction, and implantation defect. Objective: To compare in vitro fertilization (IVF) cycle success rates of women with endometriosis who were treated with letrozole + gonadotropin (LA) vs. placebo + gonadotropin (PA). Materials and Methods: This double-blind, randomized clinical trial study was conducted with ۹۴ infertile women with endometriosis (۴۷ in the LA group and ۴۷ in the PA group) who were candidates for IVF, from April-June ۲۰۲۱. For all participants, the long agonist protocol was applied. In both groups, gonadotropin-releasing hormone agonist was prescribed in the mid-luteal stage and from the third day of the cycle, and gonadotropin was started and its doses were regulated based on the patient’s age, serum anti-Mullerian hormone and follicle-stimulating hormone. From the third day of the menstrual cycle, ۵ mg of letrozole daily for ۵ days prescribed for LA group, while placebo prescribed for PA on the identical days and duration. After embryo transfer, biochemical and clinical pregnancy were measured in the ۲ groups. Results: The gonadotropin dosage (p < ۰.۰۱) and estradiol level (p = ۰.۰۲) on the human chorionic gonadotropin administration day were significantly lower in the LA group compared with in the PA group. Fetus transfer was done for ۳۲ women. No significant differences were detected between the study groups regarding biochemical or clinical pregnancy (p = ۰.۷۲ for both). Conclusion: Letrozole as a co-treatment drug in the IVF cycle of women with endometriosis can significantly reduce the gonadotropin dosage and estradiol level with the same pregnancy rates.

Authors

Mahbod Ebrahimi

Department of Obstetrics and Gynecology, Yas Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Firoozeh Akbari Asbagh

Department of Obstetrics and Gynecology, Yas Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Fatemeh Davari Tanha

Department of Obstetrics and Gynecology, Yas Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Hamideh Pakniat

Department of Obstetrics and Gynecology, Yas Hospital, Tehran University of Medical Sciences, Tehran, Iran. Department of Obstetrics and Gynecology, Faculty of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.

Elham Feizabad

Department of Obstetrics and Gynecology, Yas Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Yasin Rasouli

Faculty of Pharmacy, University of Szeged, Hungary.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Ozkan S, Murk W, Arici A. Endometriosis and infertility: Epidemiology ...
  • Abd Rabbo MS, Elmaghraby HA, Mashali NA, Moneim MEA. Effect ...
  • Abu Hashim H. Aromatase inhibitors for endometriosis-associated infertility; Do we ...
  • Pavone ME, Bulun SE. Aromatase inhibitors for the treatment of ...
  • Akbari Asbagh F, Davari Tanha F, Rezaei Z, Ebrahimi M, ...
  • Suzuki T, Izumi ShI, Matsubayashi H, Awaji H, Yoshikata K, ...
  • Tavmergen E, Ulukus M, Goker EN. Long-term use of gonadotropin-releasing ...
  • Lee KH, Kim ChH, Suk HJ, Lee YJ, Kwon SK, ...
  • Yarali H, Esinler I, Polat M, Bozdag G, Tiras B. ...
  • Goswami SK, Das T, Chattopadhyay R, Sawhney V, Kumar J, ...
  • Mitwally MFM, Casper RF. Aromatase inhibition improves ovarian response to ...
  • Schwartz K, Llarena NC, Rehmer JM, Richards EG, Falcone T. ...
  • Inoue T, Ono Y, Yonezawa Y, Kishi J, Emi N. ...
  • Chen TJ, Zheng WL, Liu CH, Huang I, Lai HH, ...
  • Harb HM, Gallos ID, Chu J, Harb M, Coomarasamy A. ...
  • Opøien HK, Fedorcsak P, Omland AK, Abyholm Th, Bjercke S, ...
  • Brosens J, Verhoeven H, Campo R, Gianaroli L, Gordts S, ...
  • Dunselman GAJ, Vermeulen N, Becker C, Calhaz-Jorge C, D'Hooghe T, ...
  • Yap C, Furness S, Farquhar C. Pre and post operative ...
  • Sallam HN, Garcia-Velasco JA, Dias S, Arici A. Long-term pituitary ...
  • Eftekhar M, Saeed L. Effect of adding letrozole to gonadotropin ...
  • Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, ...
  • ElSharkawy SS, Abd Raboo MSAD, Al Abd MM, Khamis Mohamed ...
  • Moini A, Lavasani Z, Kashani L, Mojtahedi MF, Yamini N. ...
  • Piedimonte S, Volodarsky-Perel A, Tannus S, Tan SL, Dahan MH. ...
  • نمایش کامل مراجع